Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation07-02-2024
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor PresentationNureca Ltd - 543264 - Results For The Third Quarter And Nine Months Ended December 31,. 2023
Results for the third quarter and nine months ended December 31, 2023Nureca Ltd - 543264 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board MeetingNureca Ltd - 543264 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31, 2023
Nureca Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2023Nureca Ltd - 543264 - Closure of Trading Window
Trading Window for dealing in the equity shares of the Company will remain closed from January 1, 2024 till the completion of 48 hours after the declaration of unaudited financial results for the quarter ending on December 31, 2023Nureca Ltd - 543264 - Disclosure Under Regulation 30 (5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Details of Key Managerial Personnel (''KMP'') of the Company which are authorized to determine materiality of an event or information and making disclosures to Stock Exchange(s)Nureca Ltd - 543264 - Outcome Of The Board Meeting
Appointment of Mr. Naresh Gupta as Chief Financial Officer (''CFO'') of the CompanyNureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of the unaudited financial results for second quarter and half year ended September 2023Nureca Ltd - 543264 - Related Party Transactions For The Half-Year Ended September 30, 2023
Related Party Transactions for half year ended September 30, 2023Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation